Summary Ardena Holding NV (Ardena) is a contract development and manufacturing organization.The company offers solid-state chemistry services including polymorph, salt, and co-crystal screening; bio-analytical and formulation development; early-phase clinical supply manufacturing; clinical logistics; dossier and nanomedicine development services; and others.
Its drug development and manufacturing capabilities include stability studies, clinical supply packaging and labeling, technical and regulatory support, importing and releasing clinical supplies, among others.The company has operations bioanalytical and solid state research facilities in Assen, and Amsterdam, the Netherlands.
Ardena is headquartered in Ghent, Belgium.
Ardena Holding NV - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Report Synopsis COVID-19 Pandemic effect on the global branched chain amino acids (BCAAs) market varied materially by country and end-use application, depending on the timing of the outbreak and consumer behavior. Overall, the impact of coronavirus on global BCAAs was moderate in 2020 and expected to recover significantly...
184 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Algae Fats Market to Reach $1.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Algae Fats estimated at US$875.5 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at aCAGR of 4.9% over the period 2020-2027. Foods & Supplements, one...
190 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Guar Gum Market to Reach $675.6 Million by 2027
- Amid the COVID-19 crisis, the global market for Guar Gum estimated at US$551.3 Million in the year 2020, is projected to reach a revised size of US$675.6 Million by 2027, growing at a CAGR of 2.9% over the analysis period 2020-2027. Food & Beverage,...
555 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Most R&D budgets which are so vital for innovation are largely dependent upon financial support from governments. Healthy financial performance of companies also determines the extent of willingness to reinvest earnings into R&D and new product development. The COVID-19 induced recession has now cast serious...
154 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Dimethyl Sulfoxide (DMSO) Market to Reach $256.9 Million by 2027
- Amid the COVID-19 crisis, the global market for Dimethyl Sulfoxide (DMSO) estimated at US$184.2 Million in the year 2020, is projected to reach a revised size of US$256.9 Million by 2027, growing at a CAGR of 4.9% over the analysis...
366 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- The global Label-Free Detection market is projected to reach US$1.3 billion by 2025, driven by growing drug R&D, rising competitive pressure to reduce cost of drug development and the resulting need for cost-effective and efficient screening technologies. Traditional label-based assays are beset with drawbacks...
182 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Gel Electrophoresis Market to Reach $1.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Gel Electrophoresis estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027....
191 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Pectin Market to Reach $1.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Pectin estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027. Food & Beverages, one of...
179 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Tert-butanol Market to Reach $2.6 Billion by 2027
- Amid the COVID-19 crisis, the global market for Tert-butanol estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$2.6 Billion by 2027, growing at a CAGR of 5% over the analysis period 2020-2027. Paints & Coatings,...
190 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Dimethyl Carbonate Market to Reach $515.2 Million by 2027
- Amid the COVID-19 crisis, the global market for Dimethyl Carbonate estimated at US$393.5 Million in the year 2020, is projected to reach a revised size of US$515.2 Million by 2027, growing at a CAGR of 3.9% over the analysis period 2020-2027....
Pharmaceutical
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.